May 21, 2022
May 20, 2022
May 19, 2022
May 18, 2022
May 17, 2022
Dhiren Patel, PharmD, Robert Busch, MD, and Diana Issacs, PharmD, discuss recent advances in diabetes technology and their impact on patient care.
A provider toolkit with clinically relevant resources related to diagnosis and management of central precocious puberty.
Our Disease State Series was born out of the idea of providing the most practical information and resources to clinicians. In this installment, we will be focusing on thyroid disorders.
A pair of experts in the management of diabetes review the role of insulin therapy and review the approval process for biosimilars, including the FDA's approval of the first interchangeable insulin biosimilar.
May 16, 2022
A University of Surrey-led study found patients achieving optimal glucose control in the first 12 months proceeding a T2D diagnosis had a lower risk of cardiovascular events than their counterparts who did not achieve optimal glucose control.
May 13, 2022
Announced on May 13, the approval indicates Eli Lilly and Company's novel dual GLP-1/GIP agonist, tirzepatide (Mounjaro), for use as an adjunct to diet and exercise to improve blood sugar in adult patients with type 2 diabetes.
A systematic review and meta-analysis from AACE 2022 provides an overview of the potential associations between thyroid dysfunction, including both hypothyroidism and hyperthyroidism, and risk of Parkinson disease.
Results of a survey and literature review presented at AACE 2022 detail the lack of formal nutrition education available in endocrinology fellowship programs as well as the desire to see a greater emphasis placed on nutrition education in these programs.
May 12, 2022
Data presented at AACE 2022 detail levoketoconazole-specific effects observed among patients with endogenous Cushing's syndrome from the phase 3 LOGICS trial.